Phase I study of E7389 administered by 1 hour infusion every 21 days
Rubin, E. H., Rosen, L., Rajeev, V., Wiggins, L., Sicam, J., Silberman, S., Shapiro, G.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Dose escalation and pharmacokinetic (pk) study of E 7389, a microtubule-binding drug in patients (pts) with advanced solid tumors
Desai, K. K., Goel, S., Mita, A., Silberman, S., Sicam, J., Woeppel, S., Macapinlac, M., Berg, K., Rowinski, E., Mani, S.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article